Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Wiesner

Showing results (41-50 of 306) with videos related to

Pageof 31
Sort By:
Transplantation Proceedings|February 1, 1989
Advanced liver failure predisposes to cyclosporine-induced central nervous system symptoms after liver transplantationP C de Groen, R H Wiesner, R A Krom
Transplantation Proceedings|April 1, 1988
Cyclosporine A-induced side effects related to a low total serum cholesterol level: an indication for a free cyclosporine A assay?P C de Groen, R H Wiesner, R A Krom
Der Anaesthesist|November 27, 2004
[Why does blood have a pH-value of 7.4? The theory of acid-base management]M H Dueck, M Paul, R H Wiesner, et al.
Journal of Neurochemistry|September 1, 1995
Concentrations of 3,4-dihydroxyphenylalanine and catecholamines and metabolites in brain in an anhepatic model of hepatic encephalopathyR Hadesman, R H Wiesner, V L Go, et al.
Mayo Clinic Proceedings|February 1, 1995
Clinical and radiologic features of cerebral edema in fulminant hepatic failureE F Wijdicks, D J Plevak, J Rakela, et al.
Gastroenterology|January 1, 1985
Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosisR H Wiesner, N F LaRusso, J Ludwig, et al.
Hepatology (Baltimore, Md.)|February 1, 1989
Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy?J Ludwig, C H Kim, R H Wiesner, et al.
Mayo Clinic Proceedings|June 1, 1989
Application of the Mayo primary biliary cirrhosis survival model to Mayo liver transplant patientsP M Grambsch, E R Dickson, R H Wiesner, et al.
Hepatology (Baltimore, Md.)|July 1, 1988
Is primary sclerosing cholangitis a progressive disease or not?R H Wiesner, P Grambsch, N F LaRusso, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 21, 2000
Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database GroupJ A Talwalkar, E Seaberg, W R Kim, et al.
Pageof 31

Showing results (41-50 of 306) with videos related to

Sort By:
Pageof 31
Transplantation Proceedings|February 1, 1989
Advanced liver failure predisposes to cyclosporine-induced central nervous system symptoms after liver transplantationP C de Groen, R H Wiesner, R A Krom
Transplantation Proceedings|April 1, 1988
Cyclosporine A-induced side effects related to a low total serum cholesterol level: an indication for a free cyclosporine A assay?P C de Groen, R H Wiesner, R A Krom
Der Anaesthesist|November 27, 2004
[Why does blood have a pH-value of 7.4? The theory of acid-base management]M H Dueck, M Paul, R H Wiesner, et al.
Journal of Neurochemistry|September 1, 1995
Concentrations of 3,4-dihydroxyphenylalanine and catecholamines and metabolites in brain in an anhepatic model of hepatic encephalopathyR Hadesman, R H Wiesner, V L Go, et al.
Mayo Clinic Proceedings|February 1, 1995
Clinical and radiologic features of cerebral edema in fulminant hepatic failureE F Wijdicks, D J Plevak, J Rakela, et al.
Gastroenterology|January 1, 1985
Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosisR H Wiesner, N F LaRusso, J Ludwig, et al.
Hepatology (Baltimore, Md.)|February 1, 1989
Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy?J Ludwig, C H Kim, R H Wiesner, et al.
Mayo Clinic Proceedings|June 1, 1989
Application of the Mayo primary biliary cirrhosis survival model to Mayo liver transplant patientsP M Grambsch, E R Dickson, R H Wiesner, et al.
Hepatology (Baltimore, Md.)|July 1, 1988
Is primary sclerosing cholangitis a progressive disease or not?R H Wiesner, P Grambsch, N F LaRusso, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 21, 2000
Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database GroupJ A Talwalkar, E Seaberg, W R Kim, et al.
Pageof 31